IM Cannabis (IMCC) Interest Expenses (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Interest Expenses of $901298.2 for Q1 2026, up 156.6% year-over-year from $351245.9 in Q1 2025, and down 79.52% quarter-over-quarter from $4.4 million in Q4 2025.
IM Cannabis (IMCC) Interest Expenses (2020 - 2026) Analysis & Trends
IM Cannabis' Interest Expenses history runs 7 years deep, the most recent figure standing at $901298.2 for Q1 2026.
- In Q1 2026, Interest Expenses rose 156.6% year-over-year to $901298.2; the TTM figure through Mar 2026 stood at $3.5 million (down 20.1% YoY), while the FY2025 annual figure was $2.5 million, down 27.94% from the prior year.
- Interest Expenses for Q1 2026 stood at $901298.2, down from $4.4 million in the prior quarter.
- The five-year high for Interest Expenses was $5.3 million in Q4 2024, with the low at -$6.0 million in Q4 2022.
- The 5-year median for Interest Expenses is $469707.2 (2023), against an average of $762926.0.
- Peak annual rise in Interest Expenses reached 1719.51% in 2022, while the deepest fall reached 2509.11% in 2022.
- IM Cannabis' Interest Expenses stood at -$6.0 million in 2022, then surged by 55.27% to -$2.7 million in 2023, then soared by 294.7% to $5.3 million in 2024, then fell by 16.35% to $4.4 million in 2025, then sank by 79.52% to $901298.2 in 2026.
- Business Quant data shows IMCC's Interest Expenses at $901298.2 in Q1 2026, $4.4 million in Q4 2025, and -$495565.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | IM Cannabis | 535,526.41 | -633,443.76 | 1.09 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Mn |
| Jun 30, 2026 | 2.11 Mn |
| Mar 31, 2026 | 901,298.24 |
| Mar 31, 2026 | 901,298.24 |
| Dec 31, 2025 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | -495,565.07 |
| Sep 30, 2025 | -495,565.07 |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | 351,245.90 |
| Mar 31, 2025 | 351,245.90 |
| Dec 31, 2024 | 5.26 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | -114,356.33 |
| Sep 30, 2024 | -114,356.33 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | 297,587.40 |
| Mar 31, 2024 | 297,587.40 |